Runying Yang

5PUBLICATIONS
68CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 08, 2026
Concurrent AXL Inhibition Enhances RAS and ERK Inhibitor Efficacy in KRAS -mutant Pancreatic and Lung Cancer.

|Jul 09, 2026
Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling.

|Feb 11, 2025
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.

Jonathan M DeLiberty, Mallory K Roach, Clint A Stalnecker

|Jun 06, 2024
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer.

Jennifer E Klomp, J Nathaniel Diehl, Jeffrey A Klomp

|Nov 08, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

Craig M Goodwin, Andrew M Waters, Jennifer E Klomp

Pageof 1

Frequent Collaborators

5 joint publications

Kirsten L Bryant

5 joint publications

Clint A Stalnecker

5 joint publications

Adrienne D Cox

4 joint publications

Emanuel F Petricoin